ENTITY
Hisamitsu Pharmaceutical Co

Hisamitsu Pharmaceutical Co (4530 JP)

39
Analysis
Health CareJapan
HISAMITSU PHARMACEUTICAL CO., INC. produces and sells pharmaceutical products. The Company's main product is anti-inflammatory analgesic plasters and poultices sold under the brand name Salonpas. Hisamitsu Pharmaceutical exports its products to North America and Southeast Asia. The Company also researches and develops antibacterial products through its related company, RRF.
more
bullishSG Holdings
07 Aug 2021 11:41

JPX Nikkei 400 Index Rebalance: Big Turnover, Big Impact & A Market Consultation

There are 41 adds and 40 deletes for the JPX NK 400 Index. One-way turnover is high at 8.16% and will result in a trade of JPY 468bn. There will be...

Logo
481 Views
Share
09 Apr 2021 06:47

🇯🇵 JAPAN • Results & Revisions 04/​​​​08 - 7&I Fast Re and Hisamitsu Dreams

RESULTS - 48% of Thursday's 29 results announcements scored positively; however, of the largest caps, only Fast Retailing (9983 JP) and Shift (3697...

Logo
380 Views
Share
24 Mar 2021 06:23

🇯🇵 JAPAN • Results & Revisions 03/​​​​23 - No Relief for Hisamitsu

Tuesday saw only one result posted for loss-making micro-cap Danto (5337 JP). Elsewhere, there were fifteen 'irregular' forecast revisions, of...

Logo
159 Views
Share
bearishFast Retailing
21 Mar 2021 19:18

BOJ Buying to Focus on TOPIX ETFs: Big Headline, Smaller Impact

The BOJ will only buy ETFs linked to the TOPIX going forward. While this makes for a big headline, the impact on the stocks is much more muted....

Logo
437 Views
Share
09 Oct 2020 07:14

🇯🇵 JAPAN • Results & Revisions: 10/​​​​​​​​​08 - Shift, Seven&I/Lawson, Hisamitsu, Nippon Shokubai

• BEST & WORST • The best and worst pair from yesterday's announcements is DAILY STATS 21 Quarterly Results Results Score: 62%...

Logo
406 Views
Share
x